Finance
Kane Biotech Secures $250,000 Insider Loan for Working Capital
Kane Biotech Inc. has accepted a $250,000 unsecured, non-interest-bearing loan from its Board Chair, Philip Renaud, to bolster working capital.

Kane Biotech Inc. has accepted a $250,000 unsecured, non-interest-bearing loan from its Board Chair, Philip Renaud, to bolster working capital.

A new FDIC report reveals a fundamental shift in agricultural lending from income-based to collateral-based, signaling broader implications for B2B working capital...

Joint research by PYMNTS Intelligence and The Clearing House shows real-time payments are fundamentally altering how money is managed, reducing uncertainty for...